Synthesis, characterization and antitumor activity of lanthanum (III) complex with demethylcantharidate

Journal of Rare Earths

Volumn 23, Issue 5, 2005, Pages 596-599

  Yin, Fuling ^a   Zou, Jiajia ^a   Xu, Ling ^a   Wang, Xu ^a   Li, Rongchang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Antitumor activity; Demethylcantharidate group; Lanthanum complex; Rare earths

Indexed keywords

CHARACTERIZATION; COMPLEXATION; DRUG THERAPY; ELECTRON SPECTROSCOPY; LANTHANUM; SYNTHESIS (CHEMICAL); THERMODYNAMIC STABILITY; TISSUE; TUMORS;

ANTITUMOR ACTIVITY; BEL-7402 HUMAN HEPATIC CARCINOMA; BGC-823 HUMAN GASTRIC CARCINOMA; DEMETHYLCANTHARIDATE (DCA); HELA HUMAN CERVICAL CARCINOMA; L-60 HUMAN LEUKEMIA; LANTHANUM COMPLEX;

DRUG PRODUCTS;

EID: 30044439890     PISSN: 10020721     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Wang Hongfei, Yang Pin, Tian Yanni, et al. Experimental antitumor activity of the Ce (IV)-mitoxantrone complex and its interaction with deoxyribonucleic acid[J]. J. Inorg. Biochem., 1997, 68(2): 117.
2. Kostova I, Manolov I, Nicolova I, et al. New lanthanide complexes of 4-methyl-7-hydroxycoumarin and their pharmacological activity[J]. Eur. J. Med. Chem., 2001, 36(4): 339.
3. Chen S Y, Wang C H, Li D, et al. Study on some biologically active complexes of metal ions (I)-synthesis, characterization structure and antitumor activity of complex of 3,6-di-(dimethylamino)-dibenzopyriodonium lanthanum EDTA[J]. Sci. China B, 1989, 32(8): 918.
4. Wang Z M, Lin H K, Zhu S R, et al. Spectroscopy cytotoxicity and DNA-binding of the lanthanum (III) complex of an L-valine derivative of 1,10-phenanthroline[J]. J. Inorg. Biochem., 2002, 89(1-2): 97.
5. Wang Z M, Lin H K, Zhu S R, et al. Synthesis characterization and cytotoxicity of lanthanum (III) complexes with novel 1,10-phenanthroline-2,9-bis-alpha-amino acid conjugates[J]. Antitumor. Drug. Des., 2000, 15(6): 405.
6. Wang Guangsheng. Hydrolysis and demethylation of cantharidin on the relief of its urinary irritation[J]. Chinese Phamarceu Bull, 1983, 18(7): 18.
7. Wang G S. Medical uses of mylabris in ancient China and recent studies[J]. J. Ethnopharmacol., 1989, 26: 147.
8. Wang Guangsheng, Dong Cheng, Zhang Hezhong, et al. Effect of norcantharidin on the member of white blood cells[J]. Chinese Phamarceu Bull, 1987, 22(9): 517.
9. Wang Guangsheng, Zhong Huiyu, Huang Jinkui, et al. Results of clinical trials in 244 cases of primary hepatoma with norcantharidin[J]. Chinese Phamarceu Bull., 1986, 21(2): 90.
10. Yin Fuling, Shen Jia, Zou Jiajia, et al. Study on the synthesis, characterization, crystal structure and antitumor activity of a bridging ligand complex of Cu (II) with 2,2′-bipyridine and demethylcantharidate[J]. Acta Chim. Sinica, 2003, 61(4): 556.
11. Liu Zhenhai, Tian Shan Lizi. Analytical Handbook, Thermal-Analysis[M]. 2nd ed. Beijing: Chemical Industry Press, 2000. 372.
12. 6[J]. Acta Phys.-Chim. Sin., 2002, 18(6): 481.
13. Wang Honghui, Zhu Naijue, Fu Heng, et al. Crystal and molecular structures of complexes of Zn, Cu, Ni, Co with demethylcantharidic acid[J]. Sci. China. Ser. B, 1987, 5: 463.
14. Ni Jiazan. Bioinorganic Chemistry of Rare Earth Elements[M]. 2nd ed. Beijing: Science Press, 2002. 318.
15. Zhou Li, Li Shulei, Chen Hui, et al. Effects of mixed rare earth change on DNA damage of embryo cell of pregnancy rat[J]. J. Chinese Rare Earth Society (in Chin.), 2004, 22(3): 390.
16. Liu Huixue, Yang Xiaoda, Wang Kui. Effect of lanthanum on proliferation and protein expression of liver cell line 7701[J]. J. Chinese Rare Earth Society (in Chin.), 2004, 22(4): 434.
17. Chen Xingan, Cheng Yonge, Ma Kangtao, et al. In Progress of Rare Earth Science in China (Chinese Rare Earth Society, ed.)[M]. Beijing: Metallurgy Press, 2000. 312.